Tri Femynor Kit
Product Images NDC 69238-1607

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tri Femynor (NDC 69238-1607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister For Pi (Tri Femynor 1)

Blister For Pi (Tri Femynor 1)
This text appears to be a set of instructions related to taking birth control pills. It provides guidance for those whose menstrual cycle begins on a day other than Sunday, instructing them to place a labeled strip based on the start date of the cycle. It also instructs to take the pills in a certain direction every week, from left to right.*
FDA Label Image

Norgestimate Chem Struc (Tri Femynor 2)

FDA Label Image

Ee Chem Struc (Tri Femynor 3)

Ee Chem Struc (Tri Femynor 3)
Ethinyl Estradiol is a synthetic form of the hormone estrogen used in many birth control pill formulations. It works by inhibiting ovulation and thickening the cervical mucus to prevent sperm from reaching the egg. Additionally, it can regulate menstrual cycles and may be used to treat conditions such as acne and endometriosis.*
FDA Label Image

Patient-info-figure (Tri Femynor 4)

Patient-info-figure (Tri Femynor 4)
This text provides information on various birth control methods and their effectiveness in preventing pregnancy. The effectiveness is rated on a scale of fewer than 1 pregnancy per 100 women per year to 85 or more pregnancies per 100 women per year. The birth control methods discussed include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, and withdrawal.*
FDA Label Image

Blister-pic (Tri Femynor 5)

Blister-pic (Tri Femynor 5)
This text appears to be instructions for using a birth control pill pack, with specific guidance for starting the pack on a day other than Sunday. It includes a diagram of the pack and instructions to take the pills left to right each week.*
FDA Label Image

Blister (Tri Femynor 6)

Blister (Tri Femynor 6)
This is a description for a medication package of Start Tri Femynor tablets (norgestimate and ethyl estradiol) manufactured in Germany. The medication is distributed by Amneal Pharmaceuticals LLC and is only available with a prescription. The package includes four weeks of tablets with specific instructions of dosage per week. The medication should be stored in USP Controlled Room Temperature, between 20-25°C and kept protected from light.*
FDA Label Image

Carton (Tri Femynor 7)

Carton (Tri Femynor 7)
Tri Femynor is a pack of oral contraceptives containing tablets of varying colors and doses of norgestimate and ethinyl estradiol. The pack contains 28 tablets, including 7 light pink tablets, 7 light red tablets, 7 red tablets, and 7 white tablets with inert ingredients. The product is intended for preventing pregnancy but does not protect against HIV infection (AIDS) and other sexually transmitted diseases. The text also includes lot and expiration date information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.